“Phosphoinositide 3-Kinase-Based Dual-Target Inhibitors for Cancer Therapy: Rational Design, Structure-Activity Relationships and Biological Evaluation: Review Paper”. ADMET and DMPK 14 (November 2, 2026). Accessed November 2, 2026. https://pub.iapchem.org/ojs/index.php/admet/article/view/3693.